<?xml version="1.0" encoding="iso-8859-1"?><?xml-stylesheet type="text/xsl" href="http://feeds.rapidfeeds.com/style/style3.xml"?>
<?xml-stylesheet type="text/css" href="http://feeds.rapidfeeds.com/style/style3.css"?>

<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule" >

  <channel>

	<title>JHTT Featured Technologies</title>
    <link>http://feeds.rapidfeeds.com/?fid4ct=44032</link>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="via" href="feeds.rapidfeeds.com/44032/" type="application/rss+xml"></atom:link>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.rapidfeeds.com/44032/" type="application/rss+xml" />
    <description>
        <![CDATA[Latest Technologies Available for Licensing]]>
    </description>
    <pubDate>Mon, 05 Nov 2012 10:10:00 EDT</pubDate>
    <lastBuildDate>Wed, 25 Jul 2012 06:21:00 EDT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RapidFeeds v0.1 -- http://www.rapidfeeds.com</generator>
    <item>
      <title>Available Technology: C11873 - Nasal Implant for Efficient Treatment of Sinusitis</title>
      <description>
Johns Hopkins researchers have developed an implant for the application of drugs directly to the sinuses. The device consists of a catheter that allows drugs to reach previously inaccessible surfaces. It is easily implanted in the nasal cavity after surgery or during an office visit. The device also features a novel magnetic fixture to connect the drug injectors. This feature creates a reliable seal for efficient medication passage. The unique construction prevents inflammation from blocking delivery to areas that need treatment the most.
    </description>
      <link>http://www.jhttonline.jhu.edu/TechnologyDetail.aspx?TechID=D5D7DFD8-ADBA-4153-B98D-918B2EDD2AA2&amp;JHURef=C11873</link>
      <guid isPermaLink="true">http://feeds.rapidfeeds.com/?iid4ct=6968588</guid>
      <pubDate>Tue, 26 Mar 2013 16:58:00 EDT</pubDate>
    </item>
    <item>
      <title>Available Technology: C12191 - PapGene Test</title>
      <description>
Johns Hopkins researchers have developed “PapGene” test, a new screening method for endometrial and ovarian cancers. This diagnostic test is easily incorporated into a routine pelvic examination. The invention uses a sequence-based method to query 12 mutations in a single liquid Pap smear. Additionally, this method does not require prior knowledge of the tumor’s genotype. This diagnostic test provides and inexpensive and accurate means of diagnosing ovarian and endometrial cancers.
    </description>
      <link>http://www.jhttonline.jhu.edu/TechnologyDetail.aspx?TechID=030816D9-DBFE-4A85-86D5-1672979E7100&amp;JHURef=C12191</link>
      <guid isPermaLink="true">http://feeds.rapidfeeds.com/?iid4ct=6968587</guid>
      <pubDate>Tue, 26 Mar 2013 16:56:00 EDT</pubDate>
    </item>
    <item>
      <title>JHU Tech in the News: Fluid From Pap Test Used to Detect Ovarian, Endometrial Cancers (C12191 - PapGene Test)</title>
      <description>
Using cervical fluid obtained during routine Pap tests, scientists at the Johns Hopkins Kimmel Cancer Center have developed a test to detect ovarian and endometrial cancers. In a pilot study, the “PapGene” test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100 percent) endometrial cancers and nine of 22 (41 percent) ovarian cancers. Watch a video about the technology: http://youtu.be/XyI-6ngal2U
    </description>
      <link>http://www.baltimoresun.com/health/sns-rt-us-cancer-pap-testbre9081as-20130109,0,723157.story</link>
      <guid isPermaLink="true">http://feeds.rapidfeeds.com/?iid4ct=6913836</guid>
      <pubDate>Thu, 10 Jan 2013 16:15:00 EDT</pubDate>
    </item>
  </channel>
</rss>







